Bonds PROMOMED DM LLC registered on the Moscow Exchange
In accordance with the Listing Rules and the submitted application, on December 18, Moscow Exchange PJSC registered 3-year bonds of the 001Р-01 series in the amount of 0.5-1 bln rubles of PROMOMED DM LLC. This is stated in the official message of the trading platform.
The issue was assigned registration number 4B02-01-00560-R-001P. Applications will be collected on December 23 from 11:00 to 15:00 (Moscow time). The benchmark rate for the 1st coupon is 9.00-9.50% per annum. The frequency of payment is 182 days. The bonds are included in the third level of the quotation list. The release is guaranteed by the production site of Biokhimik JSC (MOEX: BIOH). The technical placement is scheduled for December 25th. The organizers are Raiffeisenbank, Otkritie FC Bank (MOEX: OPEN) and Univer Capital.
At the end of November, the Expert RA rating agency assigned a credit rating to the issuer at the ruBBB + level with a stable outlook.
PROMOMED DM LLC is a management company for the group's business units and a trading house for the wholesale of manufactured products. The group includes Biokhimik JSC (Saransk, Mordovia), in particular, the plant produces a drug for the treatment of patients with COVID-19. As of December 31, 2019, according to the consolidated financial statements in accordance with IFRS, the assets of the PROMOMED DM Group amounted to 6.1 bln rubles, the capital is 1.9 bln rubles. Revenue at the end of 2019 amounted to 5.2 bln rubles, net profit - 875 mln rubles.
